Abstract
Invasive aspergillosis is a leading cause of morbidity and mortality in immunocompromised patients, particularly in individuals with haematological malignancy and in haematopoietic stem cell transplant recipients. Nowadays, the galactomannan (GM) assay has been widely used as an indication of invasive aspergillosis, even though the test is known to generate false-positive results. The aim of this study was to compare the performance of GM and real-time PCR (qPCR) to detected Aspergillus in blood samples obtained from high-risk haematological patients. Haematological patients were screened twice weekly with GM testing, which was performed by the Platelia ELISA kit. An additional sample of whole blood (4 ml) was obtained for the purpose of qPCR testing. Sixty-four samples from 12 patients with haematopoietic stem cell transplant or haematological malignancy were studied. The overall accordance between GM and qPCR tests was 96.9 % (62 samples). Only two samples showed contradictory results, with positive GM test and negative real-time PCR results. Based on the high concordance between GM and qPCR in terms of negative results, the main utility of qPCR could be in the confirmation of positive results seen with GM testing.
Similar content being viewed by others
References
Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis. 2007;45:205–16.
Houbraken J, Verweij PE, Rijs AJ, Borman AM, Samson RA. Identification of Paecilomyces variotii in clinical samples and settings. J Clin Microbiol. 2010;48:2754–61.
Aquino VR, Goldani LZ, Pasqualotto AC. Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia. 2007;163:191–202.
Johnson GL, Bibby DF, Wong S, Agrawal SG, Bustin SA. A MIQE-compliant real-time PCR assay for Aspergillus detection. PLoS One. 2012;7:e40022.
White PL, Bretagne S, Klingspor L, Melchers WJ, McCulloch E, Schulz B, et al. European Aspergillus PCR initiative. Aspergillus PCR: one step closer to standardization. J Clin Microbiol. 2010;48:1231–40.
White PL, Perry MD, Loeffler J, Melchers W, Klingspor L, Bretagne S, et al. Critical stages of extraction DNA from Aspergillus fumigatus in whole blood specimens. J Clin Microbiol. 2010;48:3753–5.
Challier S, Boyer S, Abachin E, Berche P. Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis. J Clin Microbiol. 2004;42:844–6.
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycology study group (EORTC/MSG) consensus group. Clin Infect Dis. 2008;46:1813–21.
Verwer PE, van Duijn ML, Tavakol M, Bakker-Woudenberg IA, van de Sande WW. Reshuffling of Aspergillus fumigatus cell wall components chitin and β-glucan under the influence of caspofungin or nikkomycin Z alone or in combination. Antimicrob Agents Chemother. 2012;56:1595–8.
Botterel F, Farrugia C, Ichai P, Costa JM, Saliba F, Bretagne S. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients. Transpl Infect Dis. 2008;10:333–8.
Cuenca-Estrella M, Meije Y, Diaz-Pedroche C, Gomez-Lopez A, Buitrago MJ, Bernal-Martinez L, et al. Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia. J Clin Microbiol. 2009;47:379–84.
Rogers TR, Morton CO, Springer J, Conneally E, Heinz W, Kenny C, et al. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies. Br J Haematol. 2013;161:517–24.
Springer J, Morton CO, Perry M, Heinz WJ, Paholcsek M, Alzheimer M, Rogers TR, Barnes RA, Einsele H, Loeffler J, White PL. Multicenter comparison of serum and whole blood specimens for the detection of Aspergillus DNA in high-risk haematological patients. J Clin Microbiol. 2013;51:1445–50.
Acknowledgments
This work was supported by Ministério da Saúde/PPSUS/FAPERJ grants.
Conflict of interest
In the past 5 years, Dr Pasqualotto has received research grants and given paid talks for Pfizer, MSD, Astellas, United Medical (Gilead) and Bagó. All other authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
da Silva, T.V.M., Carneiro, L.C., dos Santos Ramos, F. et al. PCR as a Screening Test for Invasive Aspergillosis in Haematological Patients: A Pilot Study. Mycopathologia 177, 111–114 (2014). https://doi.org/10.1007/s11046-013-9718-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-013-9718-0